Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Liver Transplantation
NCT00582010Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in ischemia-reperfusion injury (IRI), sponsored by University of Alabama at Birmingham. Started Apr 2008; status: completed.
02
Drugs
nitric oxide
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00582010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582010.